2nd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients

2^nd How I Manage:
CAR-T Therapies and Bispecific Antibodies for my patients

September 29-October 1, 2023 – Berlin, Germany

#ESHCART2023

Chairs: Ulrich Jäger, Marie José Kersten, Loretta Nastoupil

ABOUT THE CONFERENCE:

CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, ensuring a maximum level of interaction between faculty and registered participants. In addition to the scientific and medical issues addressed during the conference, the questions of affordability of and access to these novel expensive treatments will be tackled by medical experts, representatives of patient organisations, economists, regulatory authorities and industry.

SCIENTIFIC TOPICS:
– Non-hodgkin lymphoma (NHL)
– Multiple myeloma
– Novel indications CAR T-cell therapy
– Managing toxicity of CAR-T and bispecific antibody treatment
– Real world data CAR-T
– Life after CAR T-cell therapy

LEARNING OBJECTIVES:
– Understanding of the current landscape of bispecific antibodies in NHL, MM and ALL
– Understanding of the current landscape of CAR-T cell therapy in NHL, MM and ALL
– Novel approaches and technologies in the field
– Integration of novel therapies into current clinical practice
– Understanding the management of side effects of CAR T-cell therapy and bispecific antibodies
– Understand potential indications and sequencing of CAR-T cells and bispecifics

THE PROGRAMME WILL INCLUDE:
– Keynote Lecture
– Plenary Sessions
– Meet the Expert Sessions
– Roundtables
– Debates
– Mentored Poster Walks
– Brief Oral Communications

***

ACCOMMODATION

Vienna House Andels’ Berlin Hotel (the conference venue)
Landsberger Allee 106, 10369 Berlin, Germany

In order to help you with your travel planning, a number of rooms have been blocked at a special rate for you.

For individual reservation, please click here.

For group reservation, please contact conferences@esh.org.

Deadline for abstracts and clinical cases: July 2nd, 2023 (23:59 CEST)

Clinical Cases and abstracts are eligible to be selected for an oral or a poster presentation.

CLICK HERE TO SUBMIT YOUR ABSTRACT OR CLINICAL CASE

Clinical Case Presentation:

• Clinical cases must be relevant to the topic of the meeting. 
• Maximum number of words: 500 
• Your clinical case will be submitted to peer review. 

 Abstracts:

• Your abstract can be structured (eg Objectives, Methods, Results, Conclusions) or unstructured. 
• Maximum number of words: 500 
• Your abstract will be submitted to peer review.

Vienna House Andels’ Berlin Hotel (the conference venue)

In order to help you with your travel planning, a number of rooms have been blocked at a special rate for you.

For individual reservation, please click here.

For group reservation, please contact conferences@esh.org

Vienna House Andel’s Berlin
Landsberger Allee 106, 10369 Berlin, Germany

Vienna House Andel’s Berlin is located in the district of Lichtenberg, on the border with Prenzlauer Berg and Friedrichshain.

https://www.viennahouse.com/en/andels-berlin/location.html

With the support of*:

Major Conference Partner
*******

Supporting Conference Partner
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

REGISTRATION IS OPEN!

The registration fee for the ESH 2nd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients is:

– 600€ for fully trained

– 300€ for in-training *

– 300€ Allied Health Professionals

– 600€ for Corporate

*A proof will be requested to confirm your status.

This fee includes:

• Your seat in the Conference Room
• The conference materials,
• Welcome cocktail, luncheons, refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

How to proceed :

Please make sure that your Internet browser (Firefox, Internet Explorer, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.

1. A) For Individual Registration:
2. Click on REGISTER HERE at the bottom of the page
3. Click on INDIVIDUAL REGISTRATION
4. Create an account and complete the registration form. It is very important to use the email of the participant in the form.
5. Proceed with the payment.
6. B) For Group Registration (More than one person):
7. Click on REGISTER HERE at the bottom of the page
8. Click on GROUP REGISTRATION
9. Create an account and fill in the complete details for each person that you would like to register (Use the personal email address of each participant you are registering, failure to do so will prohibit you from completing the registrations.)
10. Proceed with payment.

Cancellation policy of registration fee :

In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.

Register Here